DJIA 16,399.67 0.00 0.00%
NASDAQ 4,316.07 0.00 0.00%
S&P 500 1,919.32 15.31 0.80%
market minute promo

Geron Corp (NASDAQ: GERN)

company name or ticker

Should You Still Buy Geron?

This Week in Biotech: NW Bio Soars While Geron Goes Geronimo

Two early-stage study results, a rare hospital exemption approval in Germany, and a devastating full clinical hold for one biotech are among this week's top biotech stories.

Geron Corporation (GERN) in Focus: Stock Moves 5.6% Higher - Tale of the Tape

Geron Plunges on FDA Clinical Hold - Analyst Blog

Geron (GERN) Crumbles: Stocks Falls by 61.6% - Tale of the Tape

Geron Is A Speculative Buy Even After The Precipitous Price Decline

Why Geron, Express, and Herbalife Tumbled Today

The S&P 500 managed to end a two-day losing streak Wednesday with very modest gains, but many stocks couldn't recover from severe losses. Find out what made these three stocks drop today.

Geron Is Dead in the Water, but Not Sunk Yet

When people consider you an oncology company, losing your only oncology drug can sting.

The 4 Stocks That Dominated the Market on Wednesday

Why Geron Corporation Shares Were Mauled

Geron shares are turned upside down after updating the status of its imetelstat development program. Is this dip a buying opportunity or all the more reason to hit the exit?